If you make industrial parts, packaging or specialty products, FDA will never walk your floor. You can still learn from what its investigators write down at the plants they do inspect, because most of it has nothing to do with drugs. It has to do with running a plant.
The lessons are free
Over the last twelve months, the most-cited Form 483 observation at drug and cosmetic plants was a quality unit’s procedures not being written down or followed (21 CFR 211.22(d), 107 observations). Next came investigations of failures that did not reach a real root cause (21 CFR 211.192, 96). Equipment and maintenance was the most-cited theme overall. These are execution findings, not science findings. Every plant has the same risks.
Five GMP habits worth borrowing
- Write procedures the floor actually follows. Walk your top five procedures with the people who run them. Where the document and the floor disagree, fix one of them this week.
- Investigate to root cause. “Operator error” is where an investigation starts, not where it ends. Audit your last ten closed investigations and ask whether the same problem could happen again tomorrow.
- Put cleaning and maintenance on a schedule, with records. Unplanned downtime and quality escapes often trace back to the same missing preventive maintenance.
- Qualify suppliers before you depend on them. Know which materials could stop your line, who supplies them, and what your second source is.
- Keep records that answer “what happened to this lot?” Traceability is what customers, insurers and auditors ask for, regulated or not.
You don’t need a regulator to run a plant like one is coming. You need the habits.
Where to start
Pick the one habit above that would have prevented your last bad week, and run it for ninety days with a weekly written scorecard. That is the Operator’s Loop in miniature: understand, align, execute, learn, then hand it to your team.
Sources